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It is well-established that significant ischemia-reperfusion
injury during kidney transplantation results in increased
incidence of long-term fibrosis and rejection. To test for a
role of T cell infiltration and activation following ischemic
injury, we induced both bilateral and unilateral renal
ischemia in mice, followed by reperfusion, and then isolated
mononuclear cells. Analysis of these cells by flow cytometry
showed that 2 weeks after bilateral ischemia there was a
significant increase of CD8þ T cells. Furthermore, both CD4þ
and CD8þ T cells infiltrated the injured kidney 6 weeks after
unilateral ischemia. These T cells had increased expression of
CD69þ and CD44hiCD62L, markers of activation and
effector-memory, respectively. CD4þNK1.1þ and CD19þ
B cells were decreased in percentage both 6 and 11 weeks
after bilateral or unilateral injury. There was a significant
upregulation of IL-1b, IL-6, TNF-a, IFN-c, MIP-2, and RANTES
expression, measured by real-time PCR, 6 weeks after
unilateral renal ischemia, further indicating T cell activation.
Depletion of CD4þ and CD8þ T cells before ischemia caused
less medullary damage and reduced kidney IFN-c expression,
whereas their depletion following ischemia increased kidney
IL-1b; however, depletion of these cells had no effect on
histological damage to the kidney. Our study demonstrates
that moderate or severe kidney ischemia induces long-term T
lymphocyte infiltration and cytokine/chemokine
upregulation, leading to kidney structural changes.
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Ischemic acute kidney injury (AKI) is associated with
decreased allograft survival in patients with transplanted
kidneys and high mortality in patients with native kidneys.1,2
Kidney transplants from living unrelated donors (not well
HLA matched) with minimal ischemic injury have improved
allograft survival, compared with grafts from well matched
cadaveric donors with significant ischemia.3–6 This implies
that renal ischemia-reperfusion injury (IRI) can have
important consequences on long-term graft survival and
native kidneys.
Although much attention has focused on early injury
following an ischemic insult, the mechanisms of long-term
injury after severe ischemia are not well understood.
Renal ischemic injury has been found to permanently
damage peritubular capillaries causing hypoxia, which may
be involved in the progression of chronic renal disease after
AKI.7,8 Tubulointerstitial influx of inflammatory cells is
found in many forms of chronic renal diseases, including
‘nonimmune’ diseases such as diabetes and hypertension.9
T-lymphocyte infiltration has also been observed early after
moderate ischemia injury,10,11 however, the dynamics of
infiltrating lymphocyte populations long term after moderate
or severe ischemic injury is unknown.
It has been demonstrated that T and B lymphocytes are
important mediators in the pathogenesis of renal IRI,10,12
however, the mechanisms by which these cells induce kidney
injury is largely unknown. The trafficking of pathogenic
lymphocytes into kidneys after moderate and severe ischemic
injury has been postulated to contribute to kidney
damage;11,13,14 however the physiologic state and the
dynamics of trafficking of these populations long term after
ischemia have not been rigorously studied. Furthermore, the
activation and expression of the effector-memory phenotype
by infiltrated lymphocytes suggests the possibility that these
lymphocytes are responding to an injury-associated anti-
gen.15,16 Unlike previous studies that have simply used
immunohistochemistry to detect lymphocytes in ischemic
kidneys,14 we have developed a Percoll gradient technique11
to isolate infiltrated T lymphocytes from long-term mouse
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postischemic kidneys suitable for quantitative phenotypic
characterization by flow cytometry.
To make our observations clinically relevant for both
allograft and native kidneys, we have studied these
phenomena in both a moderate bilateral ischemia (a kin
to ischemia in native kidneys) and a severe unilateral
ischemia (a kin to IRI in an allograft). Here we report that
2 weeks after bilateral ischemia and 6 weeks after unilateral
ischemia the trafficking of CD4þ and CD8þ T cells
increased in kidneys. The infiltrating lymphocytes showed
activated and effector-memory T-cell phenotypes. Depletion
of CD4þ and CD8þ T cells before and after severe unilateral
ischemia showed that medullary injury and expression of
interferon (IFN)-g and interleukin (IL)-1b were T cell
dependent.
RESULTS
Kidney structural damage after bilateral and unilateral renal
IRI
We analyzed the kidney structural injury of cortex and medulla
of IRI mice long term after moderate and severe ischemic
injury (Figure 1). Unlike normal and sham mice kidneys, IRI
kidneys showed limited tubular epithelial injury with rare
lymphocyte infiltration in interstitium 2 weeks after 25 min of
moderate bilateral renal IRI (Figure 1a). Six weeks after 60 min
of severe unilateral renal IRI, sham and contralateral kidneys
showed normal histology, however, the IRI kidneys displayed
interstitial fibrosis and disruption of tubular architecture with
dilation of tubules and cyst formation leading to tubular
atrophy (Figure 1b). In addition, IRI kidneys were shrunken in
size to approximately half that of the contralateral kidneys 6
weeks after unilateral renal IRI.
CD4þ and CD8þ T cells infiltrate into kidneys long term after
moderate and severe ischemia
Percoll gradient was used to effectively elute mononuclear
cells from mouse kidneys and then characterize the
functional state and phenotype of infiltrating lympho-
cytes long term after renal IRI. Four-color flow cytometry
analysis of freshly isolated kidney mononuclear cells
(KMNC) revealed (Table 1) increased percentages of CD4þ
(29±7%) and CD8þ (16±2%, P¼ 0.015) T lymphocytes in
IRI kidneys compared with kidneys of sham mice (CD4þ :
11±1% and CD8þ : 6±1%) after 2 weeks of bilateral renal
IRI. However, similar percentage of CD4þ and CD8þ T cells
was observed in sham and IRI kidneys 6 weeks after bilateral
renal IRI. 6 weeks after unilateral renal IRI, we observed
a significantly increased percentage of CD4þ (48±3%,
Po0.001) and CD8þ (21±2%, Po0.001) T lymphocytes
compared with kidneys from sham mice (CD4þ : 16±1%
and CD8þ : 7±1%) and contralateral kidneys (CD4þ :
11±2% and CD8þ : 5±1%). No changes in CD4þ and
CD8þ T-cell populations were observed in any of the groups
11 weeks after unilateral renal IRI.
Infiltrating CD4þ and CD8þ T lymphocytes were activated
after ischemic injury
The expression of CD69 antigen on intrarenal CD4þ and
CD8þ T cells after long-term ischemia was analyzed. After
2 weeks of bilateral renal IRI (Figure 2a), we observed an
increased expression of CD69 on CD4þ (17±4%) and
CD8þ (9±1%, P¼ 0.001) T cells in IRI mice when
compared with sham mice (CD4þ : 6±1% and CD8þ :
2±0.3%). Similarly, increased expression of CD69 on CD4þ
(22±1%) and CD8þ (18±2%, P¼ 0.033) T cells in IRI
Normal Sham IRI
IRIContralateralSham
80µm 80µm 80µm
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Figure 1 | Mouse kidney tissue injury 2 weeks after bilateral and 6 weeks after unilateral renal IRI. Kidney histology in tissue sections
stained with H&E was observed at original magnification  200. Kidney tissue from IRI mice after 2 weeks of 25 min of bilateral ischemia
(a, upper panel) shows some proteinaceous casts in tubules compared with normal histology of normal and sham mouse kidneys. Kidney
structure 6 weeks after unilateral renal IRI (b, lower panel) shows normal histology of sham and contralateral kidneys compared with severe
kidney damage, loss of structure, and cyst formation in IRI kidneys.
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mice compared with sham mice (CD4þ : 15±2% and
CD8þ : 11±1%) was observed after 6 weeks of bilateral
renal IRI. Six weeks after unilateral ischemia (Figure 2b),
we observed a significantly increased expression of CD69 on
CD4þ (29±3%, Po0.001) and CD8þ (15±1%, P¼ 0.013)
T cells compared with kidneys from sham mice (CD4þ :
7±1% and CD8þ : 2±0.2%) and contralateral kidneys
(CD4þ : 4±1% and CD8þ : 2±0.3%). However, 11 weeks
after renal IRI, only CD4þ T cells from IRI kidneys showed
increased expression of CD69 (28±2%, Po0.001) when
compared with sham (13±2%) and contralateral
(12±0.02%) kidneys.
CD4þ and CD8þ T lymphocytes display effector-memory
phenotype
Using multiparameter flow cytometry, we analyzed the gated
lymphocyte and CD3þ T-cell areas for expression of homing
receptors CD44 and CD62L on CD4þ T cells (R3 gate) to
distinguish from naive (CD44loCD62Lhi) or effector-memory
(CD44hiCD62L) phenotype. Two weeks after bilateral renal
IRI, significantly increased percentage of effector-memory
CD4þCD44hiCD62L T cells in IRI kidneys (77±2%,
P¼ 0.001) was observed when compared with kidneys from
sham mice (54±3%; Figure 3a). Six weeks after bilateral
renal IRI, a significantly increased percentage of CD8þ
CD44hiCD62L T cells in IRI kidneys (90±2%, P¼ 0.023)
compared with sham mice (79±2%) was observed. Similarly,
6 weeks after unilateral renal IRI, the IRI kidneys showed
significantly increased percentage of CD4þCD44hiCD62L
T cells (96±1%, Po0.001) when compared with kidneys
from sham mice (71±3%) and contralateral kidneys
(65±2%; Figure 3b). A significant increase in percentage of
CD4þCD44hiCD62L T cells was observed in IRI kidneys
(93±1%, P¼ 0.004) when compared with sham (80±1%)
and contralateral kidneys (75±1%) 11 weeks after renal IRI.
NKT cells and B lymphocytes decreased after ischemic injury
Flow cytometry staining for CD4 and NK1.1 antigens was
performed to identify NKT cells (CD4þNK1.1þ ). Similar
percentage of NKT cells was observed after 2 weeks of
bilateral renal IRI. However, 6 weeks after bilateral renal IRI,
we found a significantly decreased percentage of NKT cells in
IRI kidneys (2±0.1%, P¼ 0.007) when compared with
kidneys of sham mice (4±0.4%). Eleven weeks after
unilateral renal IRI, decreased percentages of NKT cells was
observed in IRI kidneys (0.4±0.02%, P¼ 0.004) when
compared to sham (1.9±0.1%) and contralateral kidneys
(3.1±0.5%; Figure 4a).
Unexpectedly, we found that the percentage of
CD19þ B lymphocytes decreased significantly in the IRI
kidneys after 6 weeks (17±2%, P¼ 0.004) and 11 weeks
(6±1%, Po0.001) of unilateral renal IRI when compared
Table 1 | Percentage of CD4+ and CD8+ T lymphocytes in mouse kidneys after bilateral and unilateral renal IRI
Cell
Bilateral Unilateral
Phenotype
SH IRI SH IRI SH C IRI SH C IRI
(%) 2 Weeks 6 Weeks 6 Weeks 11 Weeks
CD4+ 11±1 29±7 48±1 51±2 16±1 11±2 48±3** 47±2 45±1 48±1
CD8+ 6±1 16±2* 26±1 30±3 7±1 5±1 21±2*** 32±3 34±2 27±2
C, percentage of lymphocytes of contralateral kidney; IRI, percentage of lymphocytes of ischemia-reperfusion injured kidney; SH, percentage of lymphocytes of sham kidney.
Data are expressed as means±s.e.m. (n=3 to 4 mice per group).
*P=0.015, **Po0.001 and ***Po0.001.
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Figure 2 | Increased expression of CD69þ activation marker on CD4þ and CD8þ T-cell subsets long term after ischemic injury.
Freshly isolated KMNC were stained with mAb anti-CD8þ FITC, anti-CD4þ PerCP, and anti-CD69þ PE and analyzed by flow cytometry.
Increased expression of early activation marker CD69 on CD8þ T cells after 2 (*P¼ 0.001) and 6 (*P¼ 0.033) weeks of bilateral renal IRI
(a, left panel) was observed. After 6 weeks of unilateral ischemia, both CD4þ (*Po0.001) and CD8þ (*P¼ 0.013) T cells increased CD69
expression. Increased percentage of CD4þCD69þ T cells 11 weeks after-unilateral IRI (b, right panel) was also observed. Cells were gated in
the lymphocyte and CD3þ T-cell areas and 10,000 events were collected. Values of the bar graphs represent the percentage mean±s.e.m.
(n¼ 3 to 4 per group.)
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with sham (6 weeks: 33±2%; 11 weeks: 24±1%) and
contralateral kidneys (6 weeks: 31±3%; 11 weeks: 28±1%;
Figure 4b). However, no changes were observed in mice that
underwent bilateral renal IRI with reduced ischemia times.
Effect of CD4þ and CD8þ T-cell depletion on kidney-cell
infiltration
To determine the pathophysiologic role of infiltrating CD4þ
and CD8þ T cells long term after ischemia, we depleted these
cells before and after unilateral ischemia during the 6-week
experiments. Depletion started 24 h preischemia and 3 days
postischemia and cell analysis by flow cytometry was
performed weekly in blood and after 6 weeks in kidney
samples. Blood was 98% depleted of CD4þ and CD8þ T cells
during the 6 weeks after renal IRI (Figure 5a). In kidneys, the
CD4þCD69þ , CD8þCD69þ , CD4þCD44hiCD62L, and
CD4þNK1.1þ cells were also depleted by approximately 98%,
in relationship with the cell profiles of nondepleted control
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Figure 3 | Increased expression of effector-memory CD4þCD44hiCD62L T-cell phenotype after unilateral and bilateral renal IRI.
The percentages of positive cells were obtained from the gated lymphocyte, CD3þ and CD4þ (R3) T-cell areas. Increased percentage of
CD4þCD44hiCD62L T cells in IRI kidneys (*P¼ 0.001) compared with kidneys from sham mice after 2 weeks of bilateral renal IRI is shown
(a, upper panel). Increased percentage of CD4þCD44hiCD62L T cells 6 weeks after unilateral treatment (*Po0.001; b, lower panel)
is shown. Representative dot plots show the mean percentage of positive cells±s.e.m. (n¼ 3 to 4 per group.)
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Figure 4 | Decreased percentages of CD4þNK1.1þ cells and CD19þ B cells after bilateral and unilateral renal IRI. Decreased
percentage of CD4þNK1.1þ T cells is shown in IRI kidneys after 6 weeks of bilateral (*P¼ 0.007) and 11 weeks of unilateral (*P¼ 0.004) renal
IRI when compared with control kidneys (a, left panel). The percentage of CD19þ B cells also decreased significantly in IRI kidneys after 6
(*P¼ 0.004) and 11 (*Po0.001) weeks of unilateral renal IRI (b, right panel). Values of the bar graphs represent the percentage mean±s.e.m.
(n¼ 3 to 4 per group.)
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mice (Figure 5b). After T-cell depletion, CD19þ B cells in
both control (Figure 6a) and depleted (Figure 6b) mice were
not significantly affected in both contralateral and ischemic
kidneys. However, similar decreasing of CD19þ B cells was
observed in IRI kidneys of control (15±2%, Po0.001) and
depleted (19±2%, Po0.028) mice when compared with
contralateral kidneys (control: 31±3% and depleted: 39±5%;
Figure 6c). To observe the degree of structural damage of
ischemic kidneys after 6 weeks of renal IRI in depleted mice,
the kidney histology of depleted and control mice were
compared. The damage in the cortex (Figure 7a) was similar in
control and both depleted mice, however, medullary damage
(Figure 7b) was more extensive in control and post-ischemia
depleted mice (Figure 7c) than in preischemia depleted mice.
Upregulation of cytokines and chemokines long term after
ischemia in T-cell depleted mice
Cytokine and chemokines are known to modulate lympho-
cyte and kidney cell interactions to mediate kidney injury and
fibrosis. Given that infiltrating T cells are activated and
selectively expanded in kidney long term after IRI, we
hypothesized that there would be a different upregulation of
these molecules postischemia in depleted and nondepleted
mice. Using real-time RT-PCR, a significant upregulation of
IL-1b, IL-6, tumor necrosis factor (TNF)-a, IFN-g, MIP-2,
and RANTES was seen 6 weeks after 60 min of unilateral
renal IRI in normal (nondepleted T cells), compared to sham
and contralateral kidneys. (Figure 8a). Depletion of CD4 and
CD8 T cells starting preischemia led to significant decrease in
kidney IFN-g levels. In contrast, depletion starting 3 days
after ischemia led to significant increase in IL-1b (Figure 8b).
However, the IRI kidneys of both depleted and nondepleted
groups had prominent expression levels of TNF-a and
RANTES.
DISCUSSION
These data demonstrate that a single episode of moderate or
severe kidney IRI leads to profound long-term changes in the
structure and immune response of kidneys. These changes
include the activation and expansion of effector-memory
T cells as well as the upregulation of proinflammatory
cytokines and chemokines in CD4þ and CD8þ T-cell
depleted and nondepleted mice. These proinflammatory
factors could contribute to the pathogenesis of progressive
fibrosis after severe ischemic injury, as well as prime the
kidney for further immunologic responses.
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Figure 5 | Effect of CD4þ and CD8þ T-cell depletion 6 weeks after severe ischemia. Depletion of CD4þ and CD8þ T cells in
peripheral blood was around 98% during the 6 weeks after ischemic insult (a, upper panel), in comparison to control nondepleted mice.
Depletion of CD4þCD69þ , CD8þCD69þ , CD4þCD44hiCD62L, and CD4þNK1.1þ T cells in kidneys was around 98%, in comparison
to control nondepleted mice (b, lower panel). Representative dot plot examples show the mean percentage of positive cells±s.e.m. (n¼ 4
per group.)
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The increased levels of CD4þ and CD8þ T cells in the
postischemic kidney (Table 1) are consistent with a previous
report showing infiltration of CD4þ T cells into kidneys long
term after IRI using immunohistochemical staining of tissue
sections.14 The increased infiltration of the activated CD69þ
marker T lymphocytes in both unilateral and bilateral IRI
kidneys (Figure 2), is consistent with upregulation of the
early activation marker CD69 antigen observed in allograft
rejections and some autoimmune diseases.17–20 Activated cells
produce inflammatory factors which can participate in tissue
damage including fibrosis, as observed in patients with
systemic sclerosis and pulmonary fibrosis.21,22 The high levels
of effector-memory CD4þCD44hiCD62L T cells, the
‘footprints’ of an immune response to antigens, in both
unilateral and bilateral IRI kidneys (Figure 3), are consistent
with the response to self-antigens involved in the pathogen-
esis of skeletal and intestinal ischemia induced by hypoxic
stress,23 indicating that immune response to renal IRI could
be also initiated by specific antigens. The decreased number
of NKTþ cells 6 and 11 weeks after bilateral and unilateral
renal IRI (Figure 4a), respectively, are similar to that in liver
injury24 and rheumatoid arthritis.25 Interestingly, the higher
levels of CD4þ and CD8þ T cells 6 and 11 weeks after
ischemia (Table 1) as well as the return to normal levels of
some populations as CD69þ (Figure 2) and CD44þ markers
(Figure 3) after 6 weeks, demonstrate the possible limit and
suppression of the immune response after long-term renal
IRI. Potential modulators of this immunosuppresion could
be the regulatory T cells CD4þCD25þ or CD4þCD25þ
FoxP3,26,27 as increased populations of these regulatory
T cells have been observed in long-term allogenic
transplants.28 Future studies can analyze these cells long term
after renal IRI.
This study shows that after a severe unilateral ischemic
insult, both kidneys could be affected by cellular immune
responses. This interconnection between the IRI kidney and
the contralateral one can be observed in this study in the T-
cell profiles of the contralateral kidneys (Table 1). After 6
weeks of severe unilateral renal IRI, the CD4þ and CD8þ T-
cell subsets in contralateral kidneys were lower in relationship
to the IRI kidneys, however, at the 11-week time point, these
reached approximately the same values of IRI ones. This
observation suggests that long term after ischemia was
performed, the contralateral ‘naive’ kidney can be infiltrated
by lymphocytes due to changes in IRI kidney after ischemia.
Trafficking of lymphocytes into naive kidney when contra-
lateral kidney have been exposed to IRI is consistent with, a
previous report where albuminuria was induced in naive
mice after the transfer of splenocytes from mice long term
after renal IRI.29 In contrast, the lymphocyte increase in sham
mice kidneys can be explained by cell mobilization
phenomenon to distant organs caused by the laparotomy.30
However, the key difference between sham and ischemic
kidneys as demonstrated in Figure 8 are the different T cell
cytokine/chemokine responses.
This study also demonstrates that kidneys can undergo
differential damage long term after severe unilateral ischemia
in both depleted and nondepleted mice. Previous reports
demonstrated similar results after short-term ischemia in
CD4/CD8 T-cell depleted mice,31–33 clearly suggesting both
T-cell-dependent and -independent mechanisms in action.
We cannot exclude a more significant role for CD4þ and
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Figure 6 | Decreased percentages of CD19þ B cells after unilateral renal IRI in both depleted and control (nondepleted) mice.
CD19þ B cells were plotted with CD4þ T cells to observe the difference between depleted and control nondepleted mice. No significant
difference existed between control and depleted mice. However, the percentage of CD19þ B cells decreased significantly in IRI kidneys in
both control (*Po0001; a, upper panel) and depleted (*P¼ 0.028; b, lower panel) mice, after 6 weeks of unilateral renal IRI. Values of the bar
graph (c, right panel) represent the percentage of B cells in control and depleted mice (mean±s.e.m., n¼ 4 per group).
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CD8þ T cells in less severe degrees of ischemia injury.
However, it should be noted, that the double negative T cells,
CD3þCD4CD8 that were observed in kidney after the
CD4/CD8 depletion (data not shown), could play an
important role in the induction of pathogenic cytokines
and chemokines production and structural damage of
kidneys. A similar mechanism of CD3þCD4CD8 T cells
has been observed in long-term transplants of human lung.34
Future studies will be necessary to analyze these cells long
term after renal IRI. In addition, CD19þ B cells were
observed in both depleted and nondepleted mice, but their
population 6 weeks after IRI was decreased (Figure 6).
Similarly, in a recent study we have shown a significant
decrease of B lymphocytes 24 h after renal IRI,11 suggesting
that these cells could be involved in renal repair as well.
CD19þ B lymphocytes have been implicated in the
pathogenesis of renal IRI,12 however, it is unknown how
these cells mediate kidney injury.
As demonstrated in both depleted and nondepleted mice
6 weeks after unilateral ischemia (Figure 8), the cytokines
and chemokines including IL-1b, IL-6, TNF-a, MIP-2, and
RANTES were significantly upregulated. It has been reported
that in moderate ischemia a modest upregulation of TNF-a
and RANTES and strong upregulation of IL-1b, IL-6, IFN-g,
and MIP-2 exist,35 whereas after severe ischemia strong
upregulation of TNF-a and RANTES and to a lesser extent
IL-1b, IL-6, IFN-g, and MIP-2 occur.36,37 Similarly, in
patients with acute rejection and chronic allograft nephro-
pathy significant expression of TNF-a and RANTES were
reported in comparison to the nonrejecting control group.37
Therefore, the reduced damage observed in the kidney
medulla of preischemia depleted mice when compared to
control mice (Figure 7) could be related to the low expression
of IFN-g (Figure 8b). The IFN-g produced by CD4þ and
CD8þ T lymphocytes is involved early after renal ische-
mia,38,39 and has been detected in acute and chronic kidney
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Figure 7 | Histology assessment of kidney tissue sections stained with H&E. Kidney structure in depleted and control (nondepleted)
mice 6 weeks after unilateral ischemia demonstrates damage, loss of structure and cyst formation in IRI kidneys. Pictures show the cortex
(a, upper panel) and medulla (b, lower panel) damage to control and both (preischemia and postischemia) depleted mice. Injury score
evaluation of kidneys (c), shows same damage in cortex of control and both depleted mice, but lower damage (*P¼ 0.029) in medulla of
preischemia depleted mice (mean±s.e.m., n¼ 4 to 8 per group). Original magnification was  200.
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rejections.40 However, the increased expression of IL-1b in
postischemia depleted mice could be related to the increased
structural damage of kidney observed41 and could have
distant organ affects.42
In conclusion, this study demonstrated that moderate or
severe renal ischemic insult can lead to the long-term infil-
tration of activated and effector-memory CD4þ and CD8þ
T cells, and the upregulation of cytokine and chemokine
factors. Combined CD4/CD8 T-cell depletion starting pre-
ischemia led to decreased kidney IFN-g and medullary
structural protection long term after ischemia insult.
However, depletion starting 3 days postischemia increased
IL-1b and was not tissue protective. These observations
agree with inflammatory cell infiltration and their mediators
of progressive fibrosis characterized in human allograft
and native kidneys leading to loss of kidney function.43
Future studies will be necessary to understand the detailed
roles of leukocyte populations as well as cytokines and
chemokines profiles in long-term kidney changes after
ischemic insult.
MATERIALS AND METHODS
Mice
Male C57BL/6J, 5–8 weeks of age were purchased from The Jackson
Laboratory (Bar Harbor, ME, USA). The mice were maintained
under specific pathogen-free conditions. All experiments were
performed in accordance with the guide for the Animal Care and
Use Committee guidelines.
Renal ischemia model
Established models of moderate and severe renal IRI in mice were
used.11–13 Briefly, mice were anesthetized with intraperitoneal
pentobarbital (75 mg/kg), underwent midline abdominal incisions,
and had their renal pedicles (bilateral) or the left (unilateral) pedicle
bluntly dissected. For bilateral ischemia, microvascular clamps were
placed on both renal pedicles for 25 min. For unilateral ischemia
where animals could survive longer ischemia times, a microvascular
clamp was placed on the left renal pedicle for 60 min. The clamps
were removed, wounds sutured, and the animals were allowed to
recover. Animals were monitored and maintained for 2, 6, and 11
weeks before killing. Sham animals underwent the same surgical
procedure without clamping of the renal pedicles.
Kidney histology
Kidneys were dissected from mice and tissue slices were fixed in 10%
formalin. For histological examination, formalin tissues were em-
bedded in paraffin and 4-mm sections were stained with H&E. These
sections were examined in a blinded fashion by a renal pathologist and
nephrologist. The percentage of histology changes in the cortex and
medulla were scored using a semiquantitative scale designed to evaluate
the degree of necrosis, cell loss, and necrotic casts on a five-point scale
based on extent of involvement as follows: 0, normal kidney; 0.5,
o10%; 1, 10–25%; 2, 25–50%; 3, 50–75%; and 4, 75–100%.
Isolation of lymphocytes from mouse kidneys
Lymphocytes were isolated from decapsulated kidneys using a
modified protocol previously described.11 Briefly, kidneys were
disrupted mechanically in 10 ml of RPMI 1640 medium supple-
mented with 5% of new born calf serum using a Stomacher 80
Biomaster (Sewart, UK). The samples were centrifuged at 300 g for
10 min to pellet the cells. The pellet was then suspended in 36%
Percoll (Amersham Pharmacia Biotech, Piscataway, NJ, USA), gently
overlaid onto 72% Percoll and centrifuged at 1000 g for 30 min at
room temperature. KMNC were isolated from the Percoll interface
and washed twice in medium.
Antibodies
The fluorochrome-conjugated monoclonal antibodies (mAbs) to
mouse Ags used for flow cytometry analysis were: anti-CD16/CD32
(2.4G2), anti-CD3e APC (145-2C11), anti-CD4 PerCp (RM4-5),
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Figure 8 | RT–PCR analysis of kidney cytokines and
chemokines from CD4þ and CD8þ T-cell depleted and
control mice. Total RNA was isolated from mouse kidneys 6
weeks after 60 min unilateral renal IRI. Relative gene expressions
of IL-1b, IL-6, TNF-a, IFN-g, MIP-2, and RANTES are displayed as
fold change values presented as average fold change 2DDCt
method, between IRI mice and control kidneys. High expression
(*Po0.05) of all cytokine and chemokine factors is observed in IRI
kidneys of normal nondepleted mice when compared with sham
and contralateral ones (a, upper panel). A significant (*Po0.05)
decrease of IFN-g in preischemia depleted mice, and a significant
(*Po0.05) increase of IL-1b in postischemia mice were observed
when compared to profiles of control mice (b, lower panel). Bar
graphs represent the percentage mean±s.e.m. (n¼ 4 to 8 per
group.)
Kidney International (2009) 75, 526–535 533
M Ascon et al.: Lymphocyte trafficking into ischemic kidneys long term o r i g i n a l a r t i c l e
anti-CD8b FITC (53-5.8), anti-CD19 PE (1D3), anti-CD69 PE
(H1.2F3), anti-NK1.1 PE (PK136), anti-CD44 FITC (IM7), and
anti-CD62L PE (MEL-14), anti-CD4 (GK1.5), anti-CD8 (53.6.72;
BD PharMingen, San Diego, CA, USA).
Flow cytometry analysis
KMNC were preincubated with anti-CD16/CD32 Fc receptor for
10 min to minimize nonspecific antibody binding. Cells were then
incubated with various combinations of mAbs for 25 min at 4 1C,
washed twice with FACS buffer, and fixed with 1% paraformalde-
hyde. Three-color immunofluorescence staining was analyzed using
a FACSCalibur instrument (BD Biosciences). The lymphocytes were
gated using forward and side scatter to exclude debris and dead cells
then 10,000 events were acquired in each assay for analysis.
Data were analyzed using CellQuest software (BD Biosciences,
San Diego, CA, USA).
Quantitative real-time RT-PCR analysis
Quantitation of mouse cytokine transcripts with real-time, one-step
reverse transcriptase polymerase chain reaction was performed using
the Applied Biosystems’ (Foster City, CA, USA) TaqMan assay
system.44 Reverse transcription was performed by using 50 ng total
RNA isolated from mouse kidney tissue in a 20 ml reaction volume,
and processed with the Superscript first-strand synthesis system for
RT–PCR according to the manufacturer’s protocol (Invitrogen,
Carlsbad, CA, USA). All PCR amplifications were carried out on an
ABI Prism 7300 Sequence Detection System, using a fluorogenic 50
nuclease assay (TaqMan probes). Probes and primers were designed
and synthesized by Applied Biosystems. Relative gene expressions
were calculated by using the 2DDCt method, in which Ct indicates
cycle threshold, the fractional cycle number where the fluorescent
signal reaches detection threshold.35 The normalized DCt value of
each sample was calculated using a total of three endogenous mouse
control genes (gapdh, actb, and pgk1). Fold change values are
presented as average fold change¼ 2(average Ct) for genes in treated
relative to control samples.
In vivo depletion of CD4 and CD8 lymphocyte subsets
mAbs, specific to CD4 (GK1.1) and CD8 (53.6.72) as described
before,45 were used to deplete mice of lymphocyte subsets.
Depletions were performed both before and after ischemia injuries.
One day before or after 3 days of unilateral ischemia insult, 100mg of
lymphocyte-depleting antibody or an isotype-matched control
immunoglobulin G (dose, 100mg intraperitoneally; Sigma Diag-
nostics, St Louis, MO, USA) was administered to each mouse by
intraperitoneal injection. mAb treatment was then repeated every
fourth day. The efficacy of depletion was monitored by using flow
cytometry analysis of peripheral blood cells with anti-mouse CD4
PeCp and CD8 FITC (BD PharMingen, San Diego, CA, USA).
Efficacy of depletion was measured weekly from the first day of
ischemia injury to the day of organ harvest. In this T-cell depletion
experiment, the efficacy of depletion was around 98% or greater for
both CD4þ and CD8þ T-cell subsets.
Statistical analysis
Data were expressed as mean±s.e.m. using Sigma Stat 3.0.
Statistical comparisons between two groups were performed by
the Student’s t-test. Comparisons between multiple groups were
performed by one-way ANOVA test followed by Student–Newman–-
Keuls test where appropriate. Statistical significance was determined
as Po0.05.
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